サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446550

脱灰骨マトリックスの市場規模、シェア、動向分析レポート：製品タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年

Demineralized Bone Matrix Market Size, Share, And Trend Analysis Report By Product Type (Putty, Fiber, Paste), By Application (Spinal Fusion, Dental, Joint Reconstruction), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脱灰骨マトリックスの市場規模、シェア、動向分析レポート：製品タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年02月23日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脱灰骨マトリックス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、脱灰骨マトリックスの世界市場規模は2024年から2030年にかけてCAGR 5.8％を記録し、2030年には19億7,000万米ドルに達すると予測されています。

同市場は、整形外科疾患に関連する研究の進展に対する政府の投資の増加により、大きな成長が見込まれています。例えば、ペンシルバニア大学ペレルマン医学部の整形外科プログラムは、2021年に1,000万米ドル以上のNIH助成金を獲得しており、この分野の研究の重要性を証明しています。

世界中で脊髄損傷の有病率が増加しており、市場成長を後押しすると予想されています。2022年のNIH報告によると、世界全体で毎年推定25万～50万人が脊髄損傷に苦しんでいます。これらの症例のほとんどは予防可能であり、外傷や自動車事故などの要因によって引き起こされます。米国だけでも、年間約17,000人の新規脊髄損傷症例が報告されており、推定282,000人が脊髄損傷とともに生活しています。スポーツ外傷による脊髄損傷は男性に多く、最もリスクの高い年齢層は16～30歳です。

世界中で整形外科疾患の有病率が増加していることが、市場の成長を後押しすると予想されます。例えば、2023年に発表されたLancet Rheumatologyの推計によると、2050年までに10億人近くが、最も有病率の高いタイプの関節炎である変形性関節症と診断されるといいます。同様に、GVRの内部データベースによれば、2023年には、変形性関節症に罹患する人の数は1,140万人になります。このような整形外科疾患の症例の増加は、脱灰骨マトリックス（DBM）の需要を押し上げると思われます。

同市場で事業を展開する主要企業は、製品形成とリーチの強化に主眼を置き、提携、供給契約、パートナーシップなどの戦略を採用しています。例えば、2022年3月、整形生物学的製品を開発するBone Biologics Corporationは、MTF Biologicsと供給契約を締結しました。この契約は脱灰骨マトリックス（DBM）の供給に関するものです。Bone Biologics社はrhNELL-1と担体からなる骨移植代替製品を開発しており、MTF Biologics社から供給されます。この製品は、骨形成を開始し、改善することを目的としています。

加えて、高齢化人口の増加に伴う患者基盤の拡大が市場の成長を補完します。例えば、NIHの報告によると、変形性関節症（OA）は55歳以上の80％以上が罹患する関節疾患です。また、米国における2019年から2021年のNHIS報告によると、45歳から64歳の成人の26％が医師から関節炎と診断されたと報告しています。また、65歳以上の成人のほぼ半数（47.3％）が医師から関節炎と診断されたと報告していることが分かった。

脱灰骨マトリックス市場レポートハイライト

  • 製品タイプ別では、DBMパテの成形可能な一貫性により、特定の欠損部位に正確に適合するよう移植片を調整できるため、パテセグメントが2023年の市場で最大の収益シェアを占めました。
  • 用途別では、人口の間で関節再建の症例が増加していることから、関節再建分野が予測期間中に最も速い成長率で成長すると予測されています。
  • 最終用途別では、外来患者による治療への嗜好の高まりから、外来患者施設分野が最大の収益シェアを占めています。
  • 北米は、整形外科疾患、脊椎損傷、老年人口の増加の有病率の増加と相まって、主要な市場プレイヤーの存在により、市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脱灰骨マトリックス（DBM）の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 脱灰骨マトリックス（DBM）：市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
  • 規制の枠組み

第4章 脱灰骨マトリックス（DBM）市場セグメント分析、製品タイプ別

  • 定義と範囲
  • 製品タイプの市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界の脱灰骨マトリックス（DBM）市場、製品タイプ別、2018年から2030年
  • パテ
    • パテ市場推計・予測、2018年から2030年まで
  • ファイバ
    • ファイバー市場推計・予測、2018年から2030年まで
  • スポンジ
    • スポンジ市場推計・予測、2018年から2030年まで
  • ペースト
    • ペースト市場推計・予測、2018年から2030年まで
  • ゲル
    • ジェル市場推計・予測、2018年から2030年まで
  • その他
    • その他の市場推計・予測、2018年から2030年まで

第5章 脱灰骨マトリックス（DBM）市場セグメント分析、用途別

  • 定義と範囲
  • 用途市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界の脱灰骨マトリックス（DBM）市場、用途別、2018年から2030年
  • 脊椎固定術
    • 脊椎固定術市場推計・予測、2018年から2030年まで
  • 歯科
    • 歯科市場推計・予測、2018年から2030年まで
  • 関節再建
    • 共同再建市場推計・予測、2018年から2030年まで
  • 手、足、足首
    • 手、足、足首の市場推計・予測、2018年から2030年まで
  • 長骨
    • 長骨市場推計・予測、2018年から2030年まで
  • 頭蓋顎顔面
    • 頭蓋顎顔面市場推計・予測、2018年から2030年まで

第6章 脱灰骨マトリックス（DBM）市場セグメント分析、エンド用途別

  • 定義と範囲
  • 最終用途市場シェア分析、2023年および2030年
  • セグメントダッシュボード
  • 世界の脱灰骨マトリックス（DBM）市場、最終用途別、2018年から2030年
  • 病院
    • 病院市場推計・予測、2018年から2030年まで
  • 外来施設
    • 外来施設市場推計・予測、2018年から2030年まで
    • 専門整形外科クリニック
    • 外来手術センター

第7章 脱灰骨マトリックス（DBM）市場セグメント分析、地域別、製品タイプ別、用途別、最終用途別、2018-2030年

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 地域別脱灰骨マトリックス（DBM）市場シェア、2023年および2030年：
  • 北米
    • 北米の脱灰した骨基質
    • 米国
    • カナダ
  • 欧州
    • 欧州の脱灰した骨基質
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業の分類
  • 企業プロファイル
    • Zimmer Biomet
    • Medtronic Plc
    • DePuy Synthes
    • Stryker Corporation
    • Arthrex Inc
    • SeaSpine
    • Globus Medical
    • Berkeley Advanced Biomaterials
    • XTANT MEDICAL
    • LifeNet Health
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 5 Global demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global demineralized bone matrix (DBM) market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 9 North America demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 12 U.S. demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Canada demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 15 Canada demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Europe demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 18 Europe demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 19 Europe demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Germany demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 22 Germany demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany demineralized bone matrix (dbm) market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK demineralized bone matrix (dbm) market, by product type, 2018 - 2030 (USD Million)
  • Table 25 UK demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 France demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 28 France demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 29 France demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Italy demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 31 Italy demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Spain demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 34 Spain demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 37 Denmark demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 40 Sweden demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Norway demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 43 Norway demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 China demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 50 China demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 51 China demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Japan demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 53 Japan demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 India demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 56 India demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 57 India demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 59 South Korea demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 62 Australia demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 68 Latin America demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 69 Latin America demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 72 Brazil demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 75 Mexico demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 78 Argentina demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 MEA demineralized bone matrix (DBM) market, by region, 2018 - 2030 (USD Million)
  • Table 81 MEA demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 82 MEA demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 83 MEA demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 85 South Africa demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 UAE demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 91 UAE demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait demineralized bone matrix (DBM) market, by product type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait demineralized bone matrix (DBM) market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait demineralized bone matrix (DBM) market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Demineralized bone matrix (DBM) market: outlook
  • Fig. 9 Demineralized bone matrix (DBM) competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Demineralized bone matrix (DBM) market driver impact
  • Fig. 12 Demineralized bone matrix (DBM) market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Demineralized bone matrix (DBM) market: Product type movement analysis
  • Fig. 16 Demineralized bone matrix (DBM) market: Product type outlook and key takeaways
  • Fig. 17 Putty market estimates and forecast, 2018 - 2030
  • Fig. 18 Fiber estimates and forecast, 2018 - 2030
  • Fig. 19 Sponge estimates and forecast, 2018 - 2030
  • Fig. 20 Paste estimates and forecast, 2018 - 2030
  • Fig. 21 Gel estimates and forecast, 2018 - 2030
  • Fig. 22 Others estimates and forecast, 2018 - 2030
  • Fig. 23 Demineralized bone matrix (DBM) Market: Application movement Analysis
  • Fig. 24 Demineralized bone matrix (DBM) market: Application outlook and key takeaways
  • Fig. 25 Spinal fusion market estimates and forecasts, 2018 - 2030
  • Fig. 26 Dental market estimates and forecasts, 2018 - 2030
  • Fig. 27 Joint reconstruction market estimates and forecasts, 2018 - 2030
  • Fig. 28 Hand, foot, and ankle market estimates and forecasts, 2018 - 2030
  • Fig. 29 Long bone market estimates and forecasts, 2018 - 2030
  • Fig. 30 Craniomaxillofacial market estimates and forecasts, 2018 - 2030
  • Fig. 31 Demineralized bone matrix (DBM) market: End-use movement analysis
  • Fig. 32 Demineralized bone matrix (DBM) market: End-use outlook and key takeaways
  • Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 34 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 35 Specialized orthopedic clinics market estimates and forecasts, 2018 - 2030
  • Fig. 36 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030
  • Fig. 37 Global demineralized bone matrix (DBM) market: Regional movement analysis
  • Fig. 38 Global demineralized bone matrix (DBM) market: Regional outlook and key takeaways
  • Fig. 39 North America demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 UK demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Norway demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Denmark demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Sweden demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Japan demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 China demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 India demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Australia demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Korea demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Brazil demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Mexico demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 MEA demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait demineralized bone matrix (DBM) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key company categorization
  • Fig. 91 Heat map analysis, 2022 - 2023
目次
Product Code: GVR-4-68040-201-7

Demineralized Bone Matrix Market Growth & Trends:

The global demineralized bone matrix market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to the increasing investment of the government in the advancement of research related to orthopedic diseases. For instance, in 2021, the Orthopedic Surgery program at the Perelman School of Medicine, University of Pennsylvania, secured over USD 10 million in NIH grants, further demonstrating the significance of this area of research.

Increasing prevalence of spinal cord injuries across the globe is anticipated to boost market growth. According to the NIH report of 2022, an estimated 250,000 to 500,000 individuals globally suffer from spinal cord injuries every year. Most of these cases are preventable and are caused by factors such as trauma and motor vehicle accidents. In the United States alone, about 17,000 new spinal cord injury cases are reported annually, with an estimated 282,000 individuals living with SCI. Males are more likely to experience SCI due to sports injuries, and the age group with the highest risk is between 16 to 30 years old.

The increasing prevalence of orthopedic disorders across the globe is expected to boost market growth. For instance, the Lancet Rheumatology estimates published in 2023 indicate that by 2050, almost one billion individuals will be diagnosed with osteoarthritis, the most prevalent type of arthritis. Similarly, as per the GVR internal data base, in 2023, the number of people affected with osteoarthritis are 11.4 million in 2023. Such rising cases of orthopedic disorders will boost the demand for demineralized bone matrix (DBM).

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing product formation and reach. For instance, in March 2022, Bone Biologics Corporation, a developer of orthobiologic products, signed a supply agreement with MTF Biologics. The agreement is for the supply of demineralized bone matrix (DBM). Bone Biologics is developing a bone graft substitute product that consists of rhNELL-1 and a carrier, which will be supplied by MTF Biologics. The product aims to initiate and improve bone formation.

Additionally, a growing patient base with an increasing aging population will supplement market growth. For instance, according to an NIH report, osteoarthritis (OA) is a joint disease that affects more than 80% of individuals over the age of 55. In addition, as per the NHIS report from 2019 to 2021 in the U.S., 26% of adults between the ages of 45 and 64 reported being diagnosed with arthritis by a doctor. The report also found that almost half (47.3%) of adults aged 65 or older reported being diagnosed with arthritis by a doctor.

Demineralized Bone Matrix Market Report Highlights:

  • Based on product type, the putty segment held the largest revenue share in the market in 2023 owing to the moldable consistency of DBM putty to tailor the graft to fit specific defect sites with precision
  • Based on application, the joint reconstruction segment is anticipated to grow at the fastest growth rate over the forecast period in the market owing to the rising cases of joint reconstruction among the population
  • Based on end-use, the outpatient facilities segment accounted for the largest revenue share due to the growing preference for outpatient treatment
  • North America dominated the market due to the presence of key market players coupled with the increasing prevalence of orthopedic disorders, spinal injuries, and a rising geriatric population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Demineralized Bone Matrix (DBM) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Demineralized Bone Matrix (DBM): Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Framework

Chapter 4. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Type Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Demineralized Bone Matrix (DBM) Market, by Product Type, 2018 to 2030
  • 4.5. Putty
    • 4.5.1. Putty market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Fiber
    • 4.6.1. Fiber market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Sponge
    • 4.7.1. Sponge market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Paste
    • 4.8.1. Paste market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Gel
    • 4.9.1. Gel market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Demineralized Bone Matrix (DBM) Market, by Application, 2018 to 2030
  • 5.5. Spinal Fusion
    • 5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Dental
    • 5.6.1. Dental market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Joint Reconstruction
    • 5.7.1. Joint reconstruction market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Hand, foot, and ankle
    • 5.8.1. Hand, foot, and ankle market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Long Bone
    • 5.9.1. Long bone market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Craniomaxillofacial
    • 5.10.1. Craniomaxillofacial market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Demineralized Bone Matrix (DBM) Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End-use Market Share Analysis, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Demineralized Bone Matrix (DBM) Market, by end-use, 2018 to 2030
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Outpatient facilities
    • 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Specialized Orthopedic Clinics
      • 6.6.2.1. Specialized orthopedic clinics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.3. Ambulatory Surgical Centers
      • 6.6.3.1. Ambulatory surgical centers clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Region, By Product Type, By Application, By End Use, 2018- 2030 (USD Million)

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Demineralized Bone Matrix (DBM) Market Share by Region, 2023 & 2030:
  • 7.5. North America
    • 7.5.1. North America demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. UK demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Germany demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. France demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Italy demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Spain demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Norway demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Sweden demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Denmark demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Zimmer Biomet
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Medtronic Plc
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. DePuy Synthes
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Arthrex Inc
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. SeaSpine
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Globus Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Berkeley Advanced Biomaterials
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. XTANT MEDICAL
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. LifeNet Health
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives